Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Occlutech takes important step towards approval in China 2021-06-01 19:02
Scripps Research Institute testing shows Viraleze highly active against UK COVID strain 2021-06-01 17:30
Australia's original prolonged-release melatonin now available over the counter at pharmacies 2021-06-01 17:05
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis 2021-06-01 16:00
100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand 2021-06-01 15:07
AVATAMED sets up Joint Service Lab with A*STAR's Institute of Molecular and Cell Biology to offer Precision Oncology Services 2021-06-01 09:00
Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China 2021-06-01 08:00
PENTAX Medical and Vedkang Establish Endoscopic Therapeutics Joint Venture 2021-05-31 21:00
PolyU develops biomimetic nanosheet for cancer therapy and imaging 2021-05-31 19:42
RhoVac Confirms Forecast - BRaVac Phase IIb study recruitment to close in Quarter 3 2021 2021-05-31 19:33
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery 2021-05-31 18:33
Mindray Defines Future of Imaging Technologies with New General Imaging, Women's Healthcare and Cardiology Ultrasound Solutions 2021-05-31 10:15
Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting 2021-05-31 10:00
An Taiwanese Hearing-impaired Actor, Easton Dong Calls Out the "Listen Love" Project, to Raise Concerns for Hearing-impaired Students during the Covid-19 Pandemic. 2021-05-31 08:00
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc. 2021-05-30 22:00
Year-end report, May-April 2020/21 2021-05-28 14:24
CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application 2021-05-28 08:10
Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome 2021-05-28 08:00
Essence SmartCare Launches VitalOn Remote Patient Monitoring Solution 2021-05-28 07:00
Viatris Signs Memorandum of Understanding with The Defeat NCD Partnership at the United Nations Institute for Training and Research (UNITAR) 2021-05-28 06:36
1 243 244 245 246 247 493